On Monday, Kaiser Permanente CEO Greg Adams took the stage at the American Hospital Association‘s Leadership Summit in Denver to make the case that his organization is cracking the code

GSK has results from a pivotal clinical trial showing rectal cancer patients treated with its drug avoided the need for the much more invasive surgical removal of their tumors. The

Glucagon-like peptide-1 (GLP-1) receptor agonist drugs are revolutionizing care for people with obesity, which affects more than 40% of U.S. adults, offering levels of weight loss that were previously difficult

Traci Tamiko Eto said she spent a year and a half trying to warn Mayo Clinic that its AI strategy was cutting corners on patient privacy and safety. Now she’s

AstraZeneca’s newest addition to its respiratory pipeline is an inhalable medication that could rival a Merck drug approved for treating chronic obstructive pulmonary disease (COPD). The drug, TQC721, comes from

Every health tech conference this year will feature a panel titled something like “AI and the Future of Prior Authorization: Toward a Collaborative Care Ecosystem.” The speakers will use the

A few years ago, I watched a regional nonprofit in community health and wellness come close to imploding. An executive director was let go over financial concerns. Several of her

We could all use a little help these days. Americans are lonelier than ever, and more than 1 in 5 now suffers from a mental illness. Demand for support is

Bausch + Lomb is dropping plans to develop a drug for glaucoma after the experimental treatment failed a mid-stage clinical trial, but it’s not the end of the road for

Pediatric mental health startup Handspring picked up $19 million in Series B funding this week. The company aims to help reshape how children’s mental health care is delivered — mainly